Characterization of the gut microbiota in patients with SARS-CoV-2 infection during controlled ovarian stimulation

Table 3 The IVF outcomes of the COVID-19 group and the control group

Group	Control (N = 21)	COVID-19 (N = 17)	P value
Fertilization method			0.224^b
IVF	14	8
ICSI	7	9
Oocytes retrieved	13.95 ± 6.32	14.12 ± 5.51	0.932^a
MII/oocytes (%)	88.74	90.83	0.637^b
Fertilization rate(%)	58.36	57.5	0.934^b
Total available blastocyst embryos	5.33 ± 2.87	6.29 ± 2.97	0.319^a

COVID-19, coronavirus disease 2019; IVF, in vitro fertilization; MII, metaphase II; ICSI, intracytoplasmic sperm injection. ^a independent sample t-tests; ^b chi-square test;

ISSN: 1757-2215